ArticleCancer gene therapy2022

miR-550a-3p is a prognostic biomarker and exerts tumor-suppressive functions by targeting HSP90AA1 in diffuse malignant peritoneal mesothelioma.

Rihan El Bezawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.